Inside the research
Stryker Corporation
SYK Research profile · latest available data
Price overview
$272.36
▲ +2.61 (+1.0%)
| 52w hi | $385.39 |
|---|---|
| 52w lo | $269.75 |
| Vol | 2.34M |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.19
| Short | -0.56 |
|---|---|
| Medium | -0.10 |
| Long | +0.35 |
computed 2026-09-27
Key fundamentals
Stryker Corporation
Healthcare · Medical Devices
| Market cap | $104.47B |
|---|---|
| Enterprise value | $116.44B |
| Trailing P/E | 28.25x |
| Forward P/E | 16.29x |
| EV / EBITDA | 15.79x |
| P / S (ttm) | 4.04x |
| Profit margin | 14.4% |
| Return on equity | 16.5% |
| Revenue growth | +9.4% |
| Earnings growth | +44.1% |
| Debt / equity | 64.39 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.34 | |
| Sector | +0.08 | |
| Technical | -0.37 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Risk Metrics
| Beta vs SPX | 0.57 |
|---|---|
| Corr SPX | 0.35 |
| Annual vol | 25.8% |
| Annual ret | -11.3% |
| Sharpe | -0.44 |
| Max DD | -33.2% |
Window: 504 trading days (504 obs)
Analyst Coverage
| Mean PT | $392.19 |
|---|---|
| High / Low | $465.00 / $315.00 |
| Median | $396.03 |
| Analysts | 26 |
| Strong Buy | 8 | |
|---|---|---|
| Buy | 14 | |
| Hold | 7 | |
| Sell | 0 | |
| Strong Sell | 0 |
Recent rating actions
| 2026-05-04 | Truist Securities | → Hold |
| 2026-05-04 | Barclays | → Overweight |
| 2026-05-01 | Wells Fargo | → Overweight |
| 2026-05-01 | Needham | → Buy |
| 2026-05-01 | JP Morgan | → Overweight |
| 2026-05-01 | Evercore ISI Group | → Outperform |
Officers & Board
| CEO | Kevin A. Lobo since 2012 |
|---|---|
| Founder | Homer Stryker current |
| CEO | Homer Stryker current |
| CEO | Stephen P. MacMillan 2005–2012 |
| CEO | John W. Brown 1977–2005 |
| CEO | Lloyd Lee Stryker 1969–1976 |
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-07-30 | Earnings Release, Exhibits | read |
| 2026-06-26 | Other Material Event, Exhibits | read |
| 2026-05-20 | Officer / Director Change, Exhibits | read |
| 2026-05-08 | Shareholder Vote | read |
| 2026-04-30 | Earnings Release, Exhibits | read |
| 2026-03-23 | Reg FD Disclosure, Exhibits | read |
| 2026-03-12 | Reg FD Disclosure | read |
| 2026-03-11 | Other Material Event | read |
| 2026-01-29 | Earnings Release, Exhibits | read |
| 2025-12-04 | Officer / Director Change, Reg FD Disclosure… | read |
| 2025-10-30 | Earnings Release, Exhibits | read |
| 2025-07-31 | Earnings Release, Exhibits | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-01 | King Debra | See Remarks | Withheld for tax | 533 | $173.60K |
| 2026-08-01 | Montagnino Kimberly Ann | VP, Chief Comm. Officer | Withheld for tax | 155 | $50.48K |
| 2026-08-01 | Fletcher Robert S | VP, Chief Legal Officer | Withheld for tax | 94 | $30.62K |
| 2026-08-01 | Fink M Kathryn | VP, Chief HR Officer | Withheld for tax | 111 | $36.15K |
| 2026-06-01 | Stiles Spencer S | President and COO | Gift | 1.61K | — |
| 2026-05-28 | Fletcher Robert S | VP, Chief Legal Officer | Sell | 2.81K | $861.14K |
| 2026-05-28 | Fletcher Robert S | VP, Chief Legal Officer | Sell | 165 | $50.43K |
| 2026-05-28 | Fletcher Robert S | VP, Chief Legal Officer | Sell | 1.07K | $327.89K |
| 2026-05-28 | Fletcher Robert S | VP, Chief Legal Officer | Sell | 120 | $36.51K |
| 2026-05-28 | Fletcher Robert S | VP, Chief Legal Officer | Sell | 258 | $79.67K |
Flow & Concentration
| Insider 180d net | -$100.66M |
|---|---|
| Insider buys / sells | 0 / 14 |
| Insider bias | Sellers |
| 13F holders | 9 |
| Top-5 share | 98.7% |
| HHI | 5,940 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| State Street Corp | $4.90B | 15.53M |
| Capital Research / Capital World | $610.22M | 1.94M |
| Fidelity / FMR LLC | $535.98M | 1.70M |
| Citadel Advisors | $174.76M | 555.06K |
| AQR Capital Management | $149.76M | 476.10K |
| Millennium Management | $45.61M | 144.87K |
| Renaissance Technologies | $28.74M | 91.30K |
| Bridgewater Associates | $3.83M | 12.15K |
| T. Rowe Price Group | $3.75M | 11.92M |
As of 2026-06-30
Dividends
| Yield (TTM) | 0.95% |
|---|---|
| $ / share (TTM) | $2.60 |
| 5y CAGR | +7.6% |
Annual dividend per share
| 2021 | $2.58 |
|---|---|
| 2022 | $2.83 |
| 2023 | $3.05 |
| 2024 | $3.24 |
| 2025 | $3.40 |
| 2026 | $0.88 |
Federal Contracts
| Amount | Agency | Description |
|---|---|---|
| $7.46M | Department of Defense | SPD/HLD SUPPORT SERVICES |
| $3.64M | Department of Veterans Affairs | MAKO 4 ROBOTIC SYSTEM |
| $3.58M | Department of Veterans Affairs | STRYKER BARIATRIC BEDS (MV3) AND MATTRESSES |
| $3.28M | Department of Defense | 8510009272!FIXATION SET,EXTERN |
| $3.28M | Department of Veterans Affairs | STRYKER BED PURCHASE FOR ROCKY MOUNTAIN REGIONAL VA MEDICAL CENTER |
| $3.24M | Department of Veterans Affairs | ASHEVILLE VA OR LIGHTING SYSTEM |
| $3.06M | Department of Veterans Affairs | ANKLE SETS |
| $2.86M | Department of Veterans Affairs | LIFEPAK DEFIBRILLATORS |
SEC Filings
The Long Run
FY 2009–2025 · 17 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $25.12B | +8.6% | |
| Gross profit | $3.33B | -1.3% | |
| Operating income | $4.89B | +7.3% | |
| Net income | $654.00M | -2.7% | |
| Cash from ops | $5.04B | +9.5% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $269.93 | $275.84 | $268.69 | $272.36 | 2.34M |
| Sep 24 | $273.22 | $275.71 | $269.73 | $269.75 | 2.29M |
| Sep 23 | $274.46 | $277.10 | $271.45 | $273.40 | 2.72M |
| Sep 22 | $277.00 | $278.99 | $274.99 | $275.09 | 2.36M |
| Sep 21 | $274.58 | $276.87 | $272.00 | $274.19 | 2.76M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →